Showing 281-290 of 325 grants

Title Institution Researcher Program Duration Total Award Amount
Dock2-mediated T cell migration as a targetable shared mechanism in autoimmunity University of Pittsburgh Alok Joglekar Cures 01-September-2025 to 31-August-2026 $149,999.05
Defining the Antigenic Landscape of Islet-Infiltrating T cells in Type 1 Diabetes University of Pittsburgh Alok Joglekar Cures 01-March-2023 to 28-February-2026 $900,000.00
MRI of Pancreas Perfusion in Response to Glucose University of Texas at Austin Jack Virostko Cures 01-July-2023 to 30-June-2025 $179,406.56
Can Addition of Pioglitazone to SGLT2 Inhibitor in Type 1 Diabetic Patients Amplify the Decrease in HbA1c and Mitigate Diabetic Ketoacidosis Risk? University of Texas Health Science Center at San Antonio Muhammad Abdul-Ghani Improving Lives 01-June-2019 to 31-December-2026 $1,573,835.31
Structural approaches to understand biased insulin signaling and design glucose-binding proteins for smart insulin therapeutics University of Utah Amber Vogel Improving Lives 01-March-2024 to 28-February-2027 $228,995.00
Optimization of fast-acting venom insulins as therapeutic candidates for T1D University of Utah Helena Safavi Improving Lives 01-September-2022 to 31-August-2026 $890,372.53
Randomized trial of semaglutide for diabetic kidney disease in type 1 diabetes University of Washington Ian De Boer Improving Lives 01-September-2023 to 31-August-2026 $2,107,411.00
Thermally responsive minimally invasive proangiogenic placeholder for cell transplantation for Type 1 Diabetes University of Washington Patrick Stayton Cures 01-November-2025 to 31-October-2028 $894,965.96
METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D) University of Washington Petter Bjornstad Improving Lives 01-September-2025 to 31-August-2028 $2,040,014.30
Effects of SGLT2 inhibition on early diabetic kidney disease: interrogation of renal energetics by functional imaging and single-cell transcriptomics University of Washington Petter Bjornstad Improving Lives 01-June-2024 to 30-November-2025 $488,511.63